Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Immunogenicity and safety of an inactivated trivalent split influenza virus vaccine in young children with recurrent wheezing.

Bae EY, Choi UY, Kwon HJ, Jeong DC, Rhim JW, Ma SH, Lee KI, Kang JH.

Clin Vaccine Immunol. 2013 Jun;20(6):811-7. doi: 10.1128/CVI.00008-13. Epub 2013 Mar 27.

PMID:
23536692
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].

Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2003 Jul;24(7):570-3. Chinese.

PMID:
12975010
[PubMed - indexed for MEDLINE]
3.

Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study.

Tregnaghi MW, Stamboulian D, Vanadía PC, Tregnaghi JP, Calvari M, Fragapane E, Casula D, Pellegrini M, Groth N.

Viral Immunol. 2012 Jun;25(3):216-25. doi: 10.1089/vim.2011.0063.

PMID:
22691101
[PubMed - indexed for MEDLINE]
4.

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age.

Pavia-Ruz N, Angel Rodriguez Weber M, Lau YL, Nelson EA, Kerdpanich A, Huang LM, Silas P, Qaqundah P, Blatter M, Jeanfreau R, Lei P, Jain V, El Idrissi M, Feng Y, Innis B, Peeters M, Devaster JM.

Hum Vaccin Immunother. 2013 Sep;9(9):1978-88. doi: 10.4161/hv.25363. Epub 2013 Jun 19.

PMID:
23782962
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Immunogenicity and safety of Intanza(®)/IDflu(®) intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial.

Hoon Han S, Hee Woo J, Weber F, Joo Kim W, Ran Peck K, Il Kim S, Hwa Choi Y, Myung Kim J.

Hum Vaccin Immunother. 2013 Sep;9(9):1971-7. doi: 10.4161/hv.25295. Epub 2013 Jun 18.

PMID:
23778938
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.

Pediatrics. 2006 Sep;118(3):e579-85.

PMID:
16950949
[PubMed - indexed for MEDLINE]
Free Article
7.

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.

Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD.

Vaccine. 2013 Jan 21;31(5):770-6. doi: 10.1016/j.vaccine.2012.11.074. Epub 2012 Dec 8.

PMID:
23228813
[PubMed - indexed for MEDLINE]
8.

Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age.

Vesikari T, Block SL, Guerra F, Lattanzi M, Holmes S, Izu A, Gaitatzis N, Hilbert AK, Groth N.

Pediatr Infect Dis J. 2012 May;31(5):494-500. doi: 10.1097/INF.0b013e31824bb179.

PMID:
22301476
[PubMed - indexed for MEDLINE]
9.

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.

Pépin S, Donazzolo Y, Jambrecina A, Salamand C, Saville M.

Vaccine. 2013 Nov 12;31(47):5572-8. doi: 10.1016/j.vaccine.2013.08.069. Epub 2013 Sep 7.

PMID:
24016810
[PubMed - indexed for MEDLINE]
10.

Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.

Mitchell DK, Ruben FL, Gravenstein S.

Pediatr Infect Dis J. 2005 Oct;24(10):925-7.

PMID:
16220095
[PubMed - indexed for MEDLINE]
11.

Immunogenicity and safety of three 2010-2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: a double-blind and randomized trial.

Luo FJ, Yang LQ, Ai X, Bai YH, Wu J, Li SM, Zhang Z, Lu M, Li L, Wang ZY, Shi NM.

Hum Vaccin Immunother. 2013 Aug;9(8):1725-34. doi: 10.4161/hv.24832. Epub 2013 Jun 4.

PMID:
23896581
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation.

Esposito S, Salvini F, Menni F, Scala A, Salvatici E, Manzoni F, Riva E, Giovannini M, Principi N.

Vaccine. 2013 Oct 25;31(45):5149-51. doi: 10.1016/j.vaccine.2013.08.058. Epub 2013 Sep 5.

PMID:
24012567
[PubMed - indexed for MEDLINE]
13.

Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6-35 months: a randomized, double-blind, controlled phase I clinical trial.

Li YP, Li W, Liang XF, Liu Y, Huang XC, Li CG, Li RC, Wang JZ, Wang HQ, Yin WD.

Influenza Other Respir Viruses. 2013 Nov;7(6):1297-307. doi: 10.1111/irv.12028. Epub 2012 Nov 8.

PMID:
23134570
[PubMed - indexed for MEDLINE]
14.

Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.

Avila Aguero ML, Soriano-Fallas A, Umaña-Sauma MA, Ulloa-Gutierrez R, Arnoux S.

Medicina (B Aires). 2007;67(4):351-9.

PMID:
17891930
[PubMed - indexed for MEDLINE]
15.

Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months.

Kim YK, Eun BW, Kim NH, Kang EK, Lee BS, Kim DH, Lim JS.

Scand J Infect Dis. 2013 Jun;45(6):460-8. doi: 10.3109/00365548.2012.755267. Epub 2013 Jan 7.

PMID:
23294036
[PubMed - indexed for MEDLINE]
16.

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.

Langley JM, Carmona Martinez A, Chatterjee A, Halperin SA, McNeil S, Reisinger KS, Aggarwal N, Huang LM, Peng CT, Garcia-Sicilia J, Salamanca de la Cueva I, Cabañas F, Treviño-Garza C, Rodríguez-Weber MA, de la O M, Chandrasekaran V, Dewé W, Liu A, Innis BL, Jain VK.

J Infect Dis. 2013 Aug 15;208(4):544-53. doi: 10.1093/infdis/jit263. Epub 2013 Jul 11. Erratum in: J Infect Dis. 2014 May 1;209(9):1494.

PMID:
23847058
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children.

Kanra G, Marchisio P, Feiterna-Sperling C, Gaedicke G, Lazar H, Durrer P, Kürsteiner O, Herzog C, Kara A, Principi N.

Pediatr Infect Dis J. 2004 Apr;23(4):300-6. Erratum in: Pediatr Infect Dis J. 2004 Jun;23(6):503.

PMID:
15071282
[PubMed - indexed for MEDLINE]
18.

Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia.

McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N.

Pediatr Blood Cancer. 2014 May;61(5):815-20. doi: 10.1002/pbc.24863. Epub 2013 Nov 19.

PMID:
24249544
[PubMed - indexed for MEDLINE]
19.

The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.

Pan SC, Kung HC, Kao TM, Wu H, Dong SX, Hu MH, Chou AH, Chong P, Hsieh SM, Chang SC.

J Microbiol Immunol Infect. 2013 Dec;46(6):448-55. doi: 10.1016/j.jmii.2012.08.002. Epub 2012 Sep 27.

PMID:
23022464
[PubMed - indexed for MEDLINE]
20.

Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.

Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, Zhao S, Wang Y, Zhou R, Chen R.

Jpn J Infect Dis. 2011;64(3):190-4.

PMID:
21617301
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk